Opus Genetics to Participate in Upcoming Investment Conferences
Opus Genetics to Participate in Upcoming Investment Conferences GlobeNewswire November 20, 2025 RESEARCH TRIANGLE PARK, N.C., Nov. 20, 2025 (GLOBE NEWSWIRE) — Opus Genetics, Inc. (Nasdaq: IRD) (the “Company” or “Opus Genetics”), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients with inherited retinal diseases (IRDs), announced today that […]